Literature DB >> 11788233

Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes.

Yao-Chang Chen1, Shih-Ann Chen, Yi-Jen Chen, Mau-Song Chang, Paul Chan, Cheng-I Lin.   

Abstract

OBJECTIVES: This study was conducted to investigate the effects of thyroid hormone on the electrophysiological characteristics of pulmonary vein (PV) cardiomyocytes.
BACKGROUND: Hyperthyroidism is an important etiology of paroxysmal atrial fibrillation (AF). Pulmonary veins are known to initiate paroxysmal AF.
METHODS: The action potential and ionic currents were investigated in single rabbit PV and atrial cardiomyocytes with (hyperthyroid) and without (control) incubation of L-triiodothyronine using the whole-cell clamp technique.
RESULTS: Compared with the control cardiomyocytes, hyperthyroid PV and atrial cardiomyocytes had shorter action potential duration. Hyperthyroid PV cardiomyocytes had faster beating rates (1.82 +/- 0.13 Hz vs. 1.03 +/- 0.15 Hz, p < 0.005) and a higher incidence of delayed after depolarization (beating: 92% vs. 6%, p < 0.0001; non-beating: 45% vs. 3%, p < 0.005). However, only hyperthyroid PV beating cardiomyocytes had a higher incidence of early after depolarization (46% vs. 0%, p < 0.0001). The ionic current experiments showed that hyperthyroid PV beating cardiomyocytes had larger densities of overall slow inward (2.72 +/- 0.21 pA/pF vs. 2.07 +/- 0.19 pA/pF, p < 0.05), overall transient outward (1.39 +/- 0.21 pA/pF vs. 0.48 +/- 0.08 pA/pF, p < 0.001) and steady state outward currents (0.78 +/- 0.06 pA/pF vs. 0.58 +/- 0.04 pA/pF, p < 0.05) on depolarization and larger transient inward (0.021 +/- 0.004 pA/pF vs. 0.005 +/- 0.001 pA/pF, p < 0.001) on repolarization. By contrast, the hyperthyroid PV non-beating cardiomyocytes had larger densities of overall transient outward (1.01 +/- 0.14 pA/pF vs. 0.37 +/- 0.07 pA/pF, p < 0.001), steady state outward (0.61 +/- 0.06 pA/pF vs. 0.44 +/- 0.04 pA/pF, p < 0.05) and transient inward currents (0.011 +/- 0.002 pA/pF vs. 0.003 +/- 0.001 pA/pF, p < 0.05).
CONCLUSIONS: Thyroid hormone changes the electrophysiological activity of the PV cardiomyocytes. Increased automaticity and enhanced triggered activity may increase the arrhythmogenic activity of PVs in hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788233     DOI: 10.1016/s0735-1097(01)01731-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  47 in total

Review 1.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

2.  P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.

Authors:  R Gen; E Akbay; A Camsari; T Ozcan
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

3.  Classification, Etiology and Clinical Evaluation of Atrial Fibrillation.

Authors:  Ermengol Valles; Francis E Marchlinski
Journal:  J Atr Fibrillation       Date:  2008-05-16

4.  Prevalence of right atrial non-pulmonary vein triggers in atrial fibrillation patients treated with thyroid hormone replacement therapy.

Authors:  Ki-Hun Kim; Sanghamitra Mohanty; Prasant Mohanty; Chintan Trivedi; Eli Hamilton Morris; Pasquale Santangeli; Rong Bai; Amin Al-Ahmad; John David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Patrick M Hranitzky; Jason Zagrodzky; Soo G Kim; Luigi Di Biase; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2017-03-07       Impact factor: 1.900

5.  Atrial tachyarrhythmias induced by the combined effects of β1/2-adrenergic autoantibodies and thyroid hormone in the rabbit.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Alexandria Benbrook; Ling Zhang; Bing Huang; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  J Cardiovasc Transl Res       Date:  2014-06-06       Impact factor: 4.132

6.  Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins.

Authors:  Yi-Jen Chen; Yao-Chang Chen; Ching-Tai Tai; Hung-I Yeh; Cheng-I Lin; Shih-Ann Chen
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

7.  Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism.

Authors:  Stavros Stavrakis; Xichun Yu; Eugene Patterson; Shijun Huang; Sean R Hamlett; Laura Chalmers; Reji Pappy; Madeleine W Cunningham; Syed A Morshed; Terry F Davies; Ralph Lazzara; David C Kem
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

8.  Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties.

Authors:  Joachim R Ehrlich; Tae-Joon Cha; Liming Zhang; Denis Chartier; Peter Melnyk; Stefan H Hohnloser; Stanley Nattel
Journal:  J Physiol       Date:  2003-07-07       Impact factor: 5.182

9.  Nitroprusside modulates pulmonary vein arrhythmogenic activity.

Authors:  Yung-Kuo Lin; Yen-Yu Lu; Yao-Chang Chen; Yi-Jen Chen; Shih-Ann Chen
Journal:  J Biomed Sci       Date:  2010-03-20       Impact factor: 8.410

Review 10.  Arrhythmia and thyroid dysfunction.

Authors:  S Marrakchi; F Kanoun; S Idriss; I Kammoun; S Kachboura
Journal:  Herz       Date:  2014-07-04       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.